CataloniaBio members Xenopat and ZeClinics are participating in the European 3D-Neonet programme. This new international consortium, led by University College Dublin (UCD), has been created to accelerate development of oncology and ophthalmology therapies. The consortium will comprise 18 companies and academic institutions from seven countries.

Photo: Blood vessels in the retina of a mouse stained with isolectina - © Irish Tech News - University College Dublin.